Answers are grounded in this paper and cite their sources.
It is time that we begin to deal with congenital cytomegalovirus (CMV) disease as an infectious disease problem! Eighteen years have elapsed since the publication of Dr. Weller's classic articles alerting us to congenital CMV infection as a major public health problem in the United States [1,2]. Since that time, each year approximately 3000-4000 infants have been born with symptomatic disease; many of these infants have died, and almost all of the surviving children are severely damaged (mentally retarded, blind, or deaf). An additional 30 000-40 000 each year have been asymptomatic at birth, but MS^o (4500-6000) of these children have significant handicaps, such as deafness and neurological problems. In other words, in the last 18 y, 30 000-40 000 children have died or have required custodial care and major medical management for congenital CMV disease, and an additional 45 000-60 000 are deaf or have neurological problems [3-8]. During the last two decades, major strides have been made in understanding the natural history of CMV infection and disease in mothers and their infants. Also, the modes of transmission have been clearly defined [9-11]. Despite this accumulation of knowledge, however, we lack aggressiveness in dealing with this disease problem. There are at least five major areas in which we need to take more initiative: establishment of a surveillance system, education of physicians and parents regarding the problem and the means of prevention currently available, development of a suitable vaccine, detection of infected infants at birth, and initiation of clinical trials of antiviral agents.
No takes yet. Share an insight, caveat, or question.
Martha D. Yow (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: